ABCDEFGHIJKLMNOPQRSTUVWXYZAAABACADAEAFAGAHAIAJAKALAMANAOAPAQAR
1
Tau phosphorylation sitesDiane Hanger - Department of Basic and Clinical Neuroscience, King's College London, Institute of Psychiatry, Psychology & Neuroscience, UK
2
***Please refer to notes below***Protein kinase
3
Residue numberAlzheimer PHF-tauControl brain tauFoetal rat tauPSP-tauc-Abl (Tyr kinase)5' adenosine monophosphate-activated protein kinase (AMPK)Brain-specific kinase 1/2 (BRSK)Calcium-calmodulin kinase IICyclin-dependent kinase-5 (cdk5)Casein kinase 1 (CK1)Casein kinase 2 (CK2)Cyclic AMP-dependent protein kinase (PKA)Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A)Fyn (Tyr kinase)Glycogen synthase kinase-3 (GSK-3)JNKLRRK2Met (Tyr kinase) Microtubule affinity-regulating kinase (MARK)MSK1p35/41p42/p44 mitogen-activated protein kinases (ERKs1/2)p38 mitogen-activated kinase (p38MAPK)p70S6 kinasePhosphorylase kinasePKB/AKTProtein kinase C (PKC)Protein kinase N (PKN)Prostate-derived sterile 20-like kinase 1 alpha/beta (PSK1/TAOK2)Prostate-derived sterile 20-like kinase 2 (PSK2/TAOK1)Rho kinase90 kDa Ribosomal S6 kinase (RSK1/2) Stress-activated protein kinase (SAPK) 1gamma SAPK2aSAPK2bSAPK3SAPK4SGK1SRPK2Syk (Tyr kinase)Tau-tubulin kinase 1/2 (TTBK1/2)Alzheimer PHF-tauResidue number
4
T17
***T17
5
Y18A**AY18
6
Y29Y29
7
T30****T30
8
T39*T39
9
S46A*********AS46
10
T50***T50
11
T52*T52
12
S56*S56
13
S61*S61
14
T63*T63
15
S64S64
16
S68**S68
17
T69*****T69
18
T71***T71
19
T76**T76
20
T95*T95
21
T101*T101
22
T102*T102
23
T111T111
24
S113***S113
25
T123A*AT123
26
S129S129
27
S131***S131
28
T135**T135
29
S137*S137
30
T149AA****AT149
31
T153A*********AT153
32
T169*****T169
33
T175************T175
34
T181****************T181
35
S184*********S184
36
S185*****S185
37
S191*****S191
38
S195******S195
39
Y197***Y197
40
S198********S198
41
S199***********S199
42
S202*****************S202
43
T205**A***************T205
44
S208*****S208
45
S210********S210
46
T212**A******************T212
47
S214**A******************S214
48
T217****************T217
49
T220***T220
50
T231******************T231
51
S235******************S235
52
S237********S237
53
S238*S239 in rat***S238
54
S241*****S241
55
T245************T245
56
S258***********S258
57
S262*A*****************S262
58
T263******T263
59
S285*******S285
60
S289********S289
61
S293****
*S293
62
S305******
*******S305
63
Y310Y310
64
S316S316
65
T319*T319
66
S320****S320
67
S324*************S324
68
S341*S341
69
S352*******S352
70
S356**********************S356
71
T361****T361
72
T373******T373
73
T377*****T377
74
T386******T386
75
Y394****Y394
76
S396*****************S396
77
S400**********S400
78
T403********T403
79
S404************S404
80
S409*A***********S409
81
S412*******S412
82
S413**A*******S413
83
T414*******T414
84
S416A *********A *S416
85
S422**A*********S422
86
T427****T427
87
S433*****S433
88
S435*******S435
89
90
NOTESTo cite this page, please use: https://bit.ly/2JyZTbS
91
Numbering refers to 2N4R human tau isoformThis page is updated occasionally, please send any comments or amendments by clicking on the link below:
92
Diane Hanger, Department of Basic and Clinical Neuroscience, King's College London, Institute of Psychiatry, Psychology & Neuroscience
93
"A" indicates sites identified using phospho-specific tau antibodies (see comments)This page can be viewed or printed by exporting to MS Excel: File_Export_.xls
94
95
"*" indicates sites identified by direct means
96
97
Residues indicated in yellow are those for which no kinase has been identifiedUpdates
98
Date (YMD)NotesReferences
99
Hover over top corner of cells to see notes20200714TBK1 sites addedhttps://www.biorxiv.org/content/10.1101/2020.06.17.157552v1Abreha et al, 2020
100
20200820PHF-tau sites addedhttps://academic.oup.com/brain/advance-article/doi/10.1093/brain/awaa223/5893817Drummond et al 2020